Xceleron Inc.

http://www.xceleron.com

Founded in 1997 in York, UK, Xceleron provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. Xceleron pioneered the use of human microtracer and AMS and has unmatched robust processes and knowledge of experimental design. There are currently 6 drugs on the market that have used Xceleron AMS data in filing, and another 3 in late stages of development. In 2008, the company opened its US facility in Maryland. *

	Start	2006-07-26 existent
	Group	Xceleron (Group)
	Today	Xceleron (Group)
	Industry	drug discovery services
	Industry 2	drug discovery technology

	Region	Gaithersburg, MD
	Country	United States (USA)
	Street	9801 Washingtonian Blvd., Suite 290
	City	20878 Gaithersburg, MD
	Tel	+1-240-361-1900
	Fax	+1-240-361-1901
		Address record changed: 2008-12-07

Basic data	Employees	n. a.

		* Document for »About Section«: Xceleron. (6/13/11). "Press Release: Xceleron Announces Key Board and Executive Appointments. Increasing Demand from Big Pharma for Greater R&D Productivity". York.

		Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

Xceleron Inc.

More documents for Xceleron (Group)